WP
EXAS

WealthShield Partners’s Exact Sciences EXAS Stock Holding History

WealthShield Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-155
Closed -$19K – 387
2021
Q2 		$19K Buy
155
+2
+1% +$239 ﹤0.01% 654
2021
Q1 		$20K Buy
+153
New +$20.9K ﹤0.01% 659

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WealthShield Partners's EXAS Position: Q3 2021 in Review

WealthShield Partners sold out of Exact Sciences (EXAS) in Q3 2021, closing a stake of 155 shares — an estimated $19K sold.

WealthShield Partners first reported a position in EXAS in Q1 2021 and held it in 2 quarters. The position peaked at $20K in Q1 2021. 602 funds tracked by Wall St. Rank hold EXAS as of Q3 2021.

  • WealthShield Partners reported no remaining Exact Sciences position as of Q3 2021 after selling out during the quarter.
  • WealthShield Partners sold 155 Exact Sciences shares in Q3 2021, an estimated $19K.
  • WealthShield Partners first reported a position in Exact Sciences in Q1 2021 and held it in 2 quarters.
  • WealthShield Partners's Exact Sciences position peaked at $20K in Q1 2021.
  • 602 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2021.

Based on WealthShield Partners's 13F filing for Q3 2021, filed 12 Nov 2021.